Effects of tofacitinib (2, 6, 10 or 20 mg/day) + methotrexate on cytokine levels in patients with rheumatoid arthritis.
Phase of Trial: Phase I
Latest Information Update: 25 Nov 2011
At a glance
- Drugs Tofacitinib (Primary) ; Methotrexate
- Indications Rheumatoid arthritis
- Focus Pharmacodynamics
- 25 Nov 2011 New trial record
- 04 Nov 2011 Results presented at the 75th Annual Scientific Meeting of the American College of Rheumatology and the 46th Annual Meeting of the Association of Rheumatology and Health Professionals.